KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsShares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Merck (MRK) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Merck (MRK) over the last 16 years, with Q4 2024 value amounting to $19.2 billion.

  • Merck's Accumulated Depreciation & Amortization rose 486.7% to $19.2 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $19.2 billion, marking a year-over-year increase of 486.7%. This contributed to the annual value of $19.2 billion for FY2024, which is 486.7% up from last year.
  • Latest data reveals that Merck reported Accumulated Depreciation & Amortization of $19.2 billion as of Q4 2024, which was up 486.7% from $18.3 billion recorded in Q4 2023.
  • Over the past 5 years, Merck's Accumulated Depreciation & Amortization peaked at $19.2 billion during Q4 2024, and registered a low of $150.0 million during Q4 2020.
  • Over the past 5 years, Merck's median Accumulated Depreciation & Amortization value was $362.5 million (recorded in 2020), while the average stood at $4.2 billion.
  • As far as peak fluctuations go, Merck's Accumulated Depreciation & Amortization plummeted by 8038.48% in 2020, and later skyrocketed by 993626.37% in 2023.
  • Over the past 5 years, Merck's Accumulated Depreciation & Amortization (Quarter) stood at $150.0 million in 2020, then rose by 9.33% to $164.0 million in 2021, then increased by 10.98% to $182.0 million in 2022, then skyrocketed by 9936.26% to $18.3 billion in 2023, then rose by 4.87% to $19.2 billion in 2024.
  • Its Accumulated Depreciation & Amortization was $19.2 billion in Q4 2024, compared to $18.3 billion in Q4 2023 and $182.0 million in Q4 2022.